Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 23, 2026
February 23, 2026
2a636aa3-3bb2-4828-83f2-b5eb7244721b
Related Documents
Potency Assessment of Active Immunotherapy Products
Guidance DocumentAugust 19, 2026Center for Biologics Evaluation and Research
Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products: Draft Guidance for Industry
Guidance DocumentSeptember 24, 2025Center for Biologics Evaluation and Research
Expedited Programs for Regenerative Medicine Therapies for Serious Conditions: Draft Guidance for Industry
Guidance DocumentSeptember 24, 2025Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.